Other studies presented offer critical insights into prostate cancer restaging using advanced imaging techniques, specifically [68Ga]Ga-PSMA-11 PET/CT and [11C]choline PET/CT, each within the context of biochemical recurrence. This evidence concerns the gene FOLH1 and Familial prostate cancer.